The DOI matches its Crossref record.
Nicotine Patch Therapy in Adolescent Smokers
Abstract
Objective. To evaluate the safety, tolerance, and efficacy of 24-hour nicotine patch therapy in adolescent smokers who were trying to stop smoking. Design. Nonrandomized, open-label, 6-month clinical trial. Setting. Five public high schools in the Rochester, MN, area. Subjects. Twenty-two adolescent smokers, aged 13 through 17 years, with current smoking rate of 20 or more cigarettes per day (cpd). Intervention. Daily nicotine patch therapy for 8 weeks (22 mg/d for 6 weeks followed by 11 mg/d for 2 weeks). Weekly individual behavioral counseling and group support continued for 8 weeks with follow up visits at 3 and 6 months and a mailed survey at 1 year. Main Outcome Measures. Self-reported smoking abstinence verified by expired air carbon monoxide of 8 ppm or less, nicotine withdrawal symptoms, adverse experiences, and blood cotinine levels. Results. Subjects had a mean ± SD smoking rate of 23.3 ± 5.0 (range, 20 to 35) cpd at study entry and 2.6 ± 1.6 years of smoking; the mean age was 15.9 ± 1.2 (range 13 through 17) years, and 68% were girls. Of the 22 participants, 19 (86%) completed patch therapy, 3 (14%) had biochemically validated smoking cessation at week 8, and 1 continued to be smoke free at 3 and 6 months after patch initiation. There was a significant decrease from baseline in the mean nicotine withdrawal scores for days 4 and 7 of week 1 and the mean for weeks 2 through 8. Skin reactions were the most common adverse event. As the worst skin reactions, 55% had erythema only, 5% had erythema and edema, and 9% had erythema and vesicles, whereas 32% had no skin reactions. Other reported adverse events were headaches (41%), nausea and vomiting (41%), tiredness (41%), dizziness (27%), and arm pain (23%). None of these were considered serious, life threatening, or led to the discontinuation of patch therapy. In adults with comparable smoking rates, we found that the adolescents had lower blood cotinine levels. Those smoking 20 to 25 cpd had cotinine levels of 146 ± 84 (adolescents) vs 260 ± 98 (adults) ng/ml, and those smoking 26 to 35 cpd had levels of 169 ± 73 vs 276 ± 110 ng/ml, respectively. Conclusion. Nicotine patch therapy seems safe in adolescent smokers. Placebo-controlled trials are needed to establish the efficacy of nicotine patch therapy in adolescents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Williams, C. L., Hayman, L. L., Daniels, S. R., Robinson, T. N., Steinberger, J., Paridon, S., & Bazzarre, T. (2002) · Circulation · doi:10.1161/01.cir.0000019555.61092.9e · Cited by 774
Investing in youth tobacco control: a review of smoking prevention and control strategies
Lantz, P. M. (2000) · Tobacco Control · doi:10.1136/tc.9.1.47 · Cited by 483
DiFranza, J. R. (2002) · Tobacco Control · doi:10.1136/tc.11.3.228 · Cited by 447
Effects of smoking and smoking abstinence on cognition in adolescent tobacco smokers.
Jacobsen, L. K., Krystal, J. H., Mencl, W. E., Westerveld, M., Frost, S. J., & Pugh, K. R. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.022 · Cited by 393
Us Public Health Service Clinical Practice Guideline: Treating Tobacco Use and Dependence
Fiore, M. C., & Staff, G. P. A. (2000) · Respiratory Care · doi:10.1177/002013240004501007 · Cited by 346
Are adolescent smokers dependent on nicotine? A review of the evidence
Colby, S. M., Tiffany, S. T., Shiffman, S., & Niaura, R. S. (2000) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(99)00166-0 · Cited by 312
Adolescent and young adult tobacco prevention and cessation: current status and future directions
Backinger, C. L. (2003) · Tobacco Control · doi:10.1136/tc.12.suppl_4.iv46 · Cited by 254
Mills, E. J., Wu, P., Lockhart, I., Wilson, K., & Ebbert, J. O. (2010) · Tobacco Induced Diseases · doi:10.1186/1617-9625-8-8 · Cited by 166
Diminished nicotine withdrawal in adolescent rats: implications for vulnerability to addiction
O’Dell, L. E., Bruijnzeel, A. W., Smith, R. T., Parsons, L. H., Merves, M. L., Goldberger, B. A., Richardson, H. N., Koob, G. F., & Markou, A. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0383-6 · Cited by 153
Killen, J. D., Robinson, T. N., Ammerman, S., Hayward, C., Rogers, J., Stone, C., Samuels, D., Levin, S. K., Green, S., & Schatzberg, A. F. (2004) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.72.4.729 · Cited by 146
Mermelstein, R. (2003) · Tobacco Control · doi:10.1136/tc.12.suppl_1.i25 · Cited by 144
“The evidence to date suggests that a substantial proportion of adolescent smokers can be classified as nicotine dependent, 11 with prevalence rates ranging from 19% 12 13 to as high as 68%, 14 depending on the sample characteristics and measurement.”
BackgroundInfluentialSmoking cessation interventions for adolescents
Garrison, M. M., Christakis, D. A., Ebel, B. E., Wiehe, S. E., & Rivara, F. P. (2003) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(03)00213-7 · Cited by 90
A psychobiological framework of the substrates that mediate nicotine use during adolescence
O'Dell, L. E. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.039 · Cited by 81
Counotte, D. S., Smit, A. B., Pattij, T., & Spijker, S. (2011) · Developmental Cognitive Neuroscience · doi:10.1016/j.dcn.2011.05.010 · Cited by 77
Metadata
- Authors
- Smith, T. A., House, R. F., Croghan, I. T., Gauvin, T. R., Colligan, R. C., Offord, K. P., Gomez-Dahl, L. C., & Hurt, R. D.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 1996-10-01
- Volume
- 98
- Issue
- 4
- Pages
- 659-667
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W1543676579
- Cited by
- 175
- References
- 0
- FWCI
- 3.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.